Revelation Biosciences, Inc. - stock earnings
REVBW Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -2.6 million USD | ? USD |
| 2023Q2 | -1.4 million USD | ? USD |
| 2023Q1 | 13.9 million USD | ? USD |
| 2022Q4 | -1.2 million USD | ? USD |
| 2022Q3 | -1.1 million USD | ? USD |
| 2022Q2 | -1.8 million USD | ? USD |
| 2022Q1 | -3.9 million USD | ? USD |
| 2021Q4 | -3.9 million USD | ? USD |
| 2021Q3 | -3.0 million USD | ? USD |
| 2021Q2 | -2.5 million USD | ? USD |
| 2021Q1 | -2.6 million USD | ? USD |
| 2020Q3 | -868 USD | ? USD |
REVBW Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 875063 USD | ? USD |
| 2022 | -10.8 million USD | ? USD |
| 2021 | -12.0 million USD | ? USD |
| 2020 | -136408 USD | ? USD |
| 2019 | -3638 USD | ? USD |
REVBW
Price: $0.01
52 week price:
Earnings Per Share: -4.77 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 5681
Market Capitalization: 1.2 million